Collusion and Price Fixing in the Generic Drug Industry

The speakers discuss the concerning allegations of collusion and price fixing among pharmaceutical companies, highlighting the impact on drug prices and patient affordability. They emphasize the need for a well-functioning generic drug market and explore potential penalties for collusion. The chapter also touches on the influence of previous litigations and the importance of finding solutions to address healthcare costs.